Artes Medical (ARTE) Misses Q2 View By 13c
More News related to ARTE
- NASDAQ Halts Tradings on Artes Medical (ARTE)
- Artes Medical (ARTE) Misses Q2 View By 13c
- Unusual 11 Mid-Day Movers 7/8: ABK, ARTE, ERII, ALTI Higher; IMB, ODP, VMW, IDCC Lower
- Artes Medical (ARTE) Misses Q1 EPS by 18c, Reiterates FY Revenue Oulook
- Artes Medical (ARTE) Registers 1.948M Shares for Holders
More News related to Earnings
- Forrester Research (FORR) Posts Q4 EPS of $0.35 Tops by 7c; Guides Q110 and FY10
- NetSol (NTWK) Reports Q2 Loss of $0.01, Misses by 2c; Reaffirms Guidance
- Rentech (RTK) Reports Q1 Loss of $0.07
- Textainer (TGH) Tops Q4 Earnings Views
- Sprint Nextel (S) Q4 Losses Narrow, But Miss Expectations
Artes Medical, Inc. (Nasdaq: ARTE) reports a Q2 loss of $0.73, 13 cents below the analyst estimate of ($0.60). Revenues for the quarter were $3.2 million, versus the consensus of $2.94 million.
Artes Medical, Inc., a medical technology company, focuses on the developing, manufacturing, and commercializing injectable aesthetic products for the dermatology and plastic surgery markets in the United States.
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
